about
Discovery and resupply of pharmacologically active plant-derived natural products: A reviewNatural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a reviewIdentification of the Lipodepsipeptide MDN-0066, a Novel Inhibitor of VHL/HIF Pathway Produced by a New Pseudomonas SpeciesIdentifying enriched drug fragments as possible candidates for metabolic engineeringMarine Mollusk-Derived Agents with Antiproliferative Activity as Promising Anticancer Agents to Overcome Chemotherapy Resistance.Marketed marine natural products in the pharmaceutical and cosmeceutical industries: tips for successCurrent status and prospects of computational resources for natural product dereplication: a review.Madurastatin B3, a rare aziridine derivative from actinomycete Nocardiopsis sp. LS150010 with potent anti-tuberculosis activity.Effects of plant-derived anti-leukemic drugs on individualized leukemic cell population profiles in Egyptian patients.Matching the power of high throughput screening to the chemical diversity of natural productsImmunomodulatory Effects of Taiwanese Neolitsea Species on Th1 and Th2 Functionality.High-content screening of natural products reveals novel nuclear export inhibitors.Efficient screening of marine extracts for protease inhibitors by combining FRET based activity assays and surface plasmon resonance spectroscopy based binding assays.Preliminary in vitro evaluation of genistein chemopreventive capacity as a result of esterification and cyclodextrin encapsulation.Medicinal Plants Used in the Treatment of Human Immunodeficiency Virus.Natural products as reservoirs of novel therapeutic agents.In-vitro evaluation of apoptotic effect of OEO and thymol in 2D and 3D cell cultures and the study of their interaction mode with DNA
P2860
Q22252341-B45A6998-7255-406C-BFDE-109308A19935Q24561401-DE6E729A-139D-4A63-AB4D-D66DBE681D07Q28547505-449BBF00-16F0-49BC-B999-7649098CC779Q28830613-5C1D7B4E-2571-458B-8E58-7F19DBABB39FQ33834080-E0333ABB-2D35-4490-954A-F45AFF02A3EBQ35096907-DB422E9A-4DEA-47DC-97DB-0EF0A2D02C2EQ35685689-4331C37A-EC00-4544-9702-C1FDFA0A4F3EQ36274891-823A0517-F4B3-49D0-B784-0F984E4EA7B9Q36503193-529A3DAD-3817-41D7-88C7-D27A1112C380Q37240957-C575FD9A-A59B-4F39-AA60-97FD96B42A1EQ38637840-E8C5830C-4792-441C-BEB6-42DF8F853797Q39094551-0644C102-96A6-4F18-84A0-F5F4878CCF92Q41841836-BD2C21CA-F7A4-49BF-91EF-D741AF7D084EQ53625641-6CE332A7-CA55-4C9C-B424-92DFEE3E7119Q54212657-EA7CCD19-AFFC-4A11-816C-2571BF07A3DFQ55217571-7BBE3708-A0CB-4E6C-89D2-401E3FA98534Q58562849-CE623EA1-060B-45AA-A132-9AAB442B790A
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Natural Products as a Foundation for Drug Discovery.
@ast
Natural Products as a Foundation for Drug Discovery.
@en
type
label
Natural Products as a Foundation for Drug Discovery.
@ast
Natural Products as a Foundation for Drug Discovery.
@en
prefLabel
Natural Products as a Foundation for Drug Discovery.
@ast
Natural Products as a Foundation for Drug Discovery.
@en
P2860
P1476
Natural Products as a Foundation for Drug Discovery.
@en
P2093
John A Beutler
P2860
P304
9.11.1-9.11.21
P356
10.1002/0471141755.PH0911S46
P577
2009-09-01T00:00:00Z